Biohaven (BHVN) Short-term Investments (2022 - 2026)
Biohaven (BHVN) reported Short-term Investments of $74.7 million for Q1 2026, down 66.68% on a YoY basis from $224.3 million in Q1 2025, and down 16.19% sequentially from $89.2 million in Q4 2025.
Biohaven (BHVN) Short-term Investments (2022 - 2026) Analysis & Trends
Biohaven (BHVN) has 5 years of Short-term Investments data on file, last reported at $74.7 million in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments fell 66.68% year-over-year to $74.7 million; the trailing twelve-month figure through Mar 2026 stood at $74.7 million (down 66.68% YoY), and the FY2025 full-year result was $89.2 million, down 76.95% from the prior year.
- Short-term Investments declined to $74.7 million in Q1 2026, from $89.2 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $386.9 million in Q4 2024 to a low of $28000.0 in Q3 2023.
- A 5-year average of $155.6 million and a median of $117.1 million in 2023 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments soared 1051421.43% in 2024 and plunged 76.95% in 2025, its largest moves.
- Tracing BHVN's Short-term Investments over 5 years: stood at $260.5 million in 2022, then plunged by 48.78% to $133.4 million in 2023, then jumped by 189.96% to $386.9 million in 2024, then sank by 76.95% to $89.2 million in 2025, then fell by 16.19% to $74.7 million in 2026.
- Business Quant data shows BHVN's Short-term Investments at $74.7 million in Q1 2026, $89.2 million in Q4 2025, and $75.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - |
| 10 | Biohaven | 2.14 Bn | 1.80 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74.74 Mn |
| Dec 31, 2025 | 89.18 Mn |
| Sep 30, 2025 | 75.37 Mn |
| Jun 30, 2025 | 239.18 Mn |
| Mar 31, 2025 | 224.33 Mn |
| Dec 31, 2024 | 386.86 Mn |
| Sep 30, 2024 | 294.43 Mn |
| Jun 30, 2024 | 197.80 Mn |
| Mar 31, 2024 | 100.71 Mn |
| Dec 31, 2023 | 133.42 Mn |
| Sep 30, 2023 | 28,000.00 |
| Jun 30, 2023 | 40.42 Mn |
| Mar 31, 2023 | 61.55 Mn |
| Dec 31, 2022 | 260.46 Mn |